Cargando…
Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells
Glioblastoma stem-like cells (GSC) are hypothesized to evade current therapies and cause tumor recurrence, contributing to poor patient survival. Existing cell surface markers for GSC are developed from embryonic or neural stem cell systems; however, currently available GSC markers are suboptimal in...
Autores principales: | Zorniak, Michael, Clark, Paul A., Umlauf, Benjamin J., Cho, Yongku, Shusta, Eric V., Kuo, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696472/ https://www.ncbi.nlm.nih.gov/pubmed/29158489 http://dx.doi.org/10.1038/s41598-017-16066-1 |
Ejemplares similares
-
Identification of a Novel Lysosomal Trafficking Peptide
using Phage Display Biopanning Coupled with Endocytic Selection Pressure
por: Umlauf, Benjamin J., et al.
Publicado: (2014) -
Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies
por: Panagides, Nadya, et al.
Publicado: (2022) -
Biopanning data bank 2018: hugging next generation phage display
por: He, Bifang, et al.
Publicado: (2018) -
Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells
por: Potez, Marine, et al.
Publicado: (2023) -
BSCI-06. Phage display biopanning identifies Amot regulating cell motility in brain metastasis-initiating cells
por: She, Chunhua, et al.
Publicado: (2021)